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ABSTRACT 
Mediator is an evolutionary conserved co-activator complex that 
regulates transcription of protein encoding genes in eukaryotes. This 
multiprotein complex was first identified in budding yeast and shown to 
be indispensable for RNA polymerase II (pol II) dependent transcription. 
Mediator is a transducer of regulatory signals from gene specific 
transcription factors to the general transcription machinery. Mediator has 
both activating and repressive functions, but the regulatory mechanisms 
are not yet completely understood. In our work, we have used a 
biochemical approach and identified four proteins, Med12, Med13, Cdk8, 
and CycC, as subunits of a repressive kinase module present in the 
Schizosaccharomyces pombe Mediator complex. Taking advantage of a 
reconstituted in vitro transcription system, we have tried to address the 
mechanism of transcriptional repression by this subcomplex. We have 
also addressed the function of the Med15 Mediator subunit, which has 
been characterized previously in other species. 
In Paper I we isolated a new form of the S. pombe Mediator complex to 
near homogeneity and denoted this complex Large (L-) Mediator. The L-
Mediator contains four additional subunit not previously identified in the 
S. pombe core Mediator complex, but present in many of the large 
Mediator complexes isolated from higher eukaryotes. In contrast to the 
core Mediator complex, L-Mediator does not interact with pol II. Based 
on our biochemistry findings and bioinformatic analysis, our data suggest 
that Med12, Med13, Cdk8, and CycC form evolutionally conserved 
kinase module. 
In Paper II we developed an in vitro transcription system reconstituted 
with all the general transcription factors purified to near homogeneity, in 
either native or recombinant form. Fission yeast pol II assisted by TFIIB, 
TFIIF, TFIIE, TFIIH, and budding yeast TBP could initiate transcription 
from the S. pombe adh1 promoter in vitro. We found that addition of the 
core Mediator in complex with pol II could stimulate basal transcription, 
while L-Mediator suppressed transcription initiation in a dose dependent 
manner. Based on our findings, we proposed a model explaining the 
repressive function of L-Mediator. 
In Paper III we systematically addressed the structural organization of 
kinase module of L-Mediator. We identified Med13 as a key architectural 
subunit, anchoring the kinase module to the rest of the Mediator complex. 
Med13 was sufficient and necessary to occlude pol II from binding to 
Mediator, whereas deletion of Cdk8 and CycC did not affect Mediator 
association with pol II.  
In Paper IV we identified two new S. pombe Mediator components. The 
evolutionary conserved Med15 subunit associated with the chromatin 
remodeling protein Hrp1 and formed transient interactions with the S. 
pombe L-Mediator complex. Genome wide association data demonstrated 
Med15 association with a distinct subset of Hrp1 bound gene promoters.  
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1 INTRODUCTION. 
The array of expressed proteins determines the identity of the individual cell in a 
multicellular organism. Therefore the pattern and level of expression of a particular 
protein must be under tight control and as a consequence, expression of the 
corresponding gene has to be accurately regulated. Genes can be regulated at many 
different levels, e.g. gene transcription, splicing, mRNA stability, translation, protein 
stability, and post-translational modifications. However, in general, regulation at the 
level of transcription is quantitatively very important. The transcription process can be 
divided into three stages: initiation, elongation, and termination, which are subjected to 
regulatory mechanisms. Transcription initiation has been described as the most 
important of these levels, providing a heavily regulated, rate-limiting step of the gene 
expression cascade. Recently, our view of transcription initiation has changed, since 
there has been a series of papers demonstrating that RNA polymerase (pol II) may 
initiate transcription, but remain in a paused position downstream of the transcription 
initiation site, waiting for regulator input that signals a switch to elongation (Margaritis 
& Holstege, 2008). 
A large number of different proteins and protein complexes with diverse enzymatic 
activities are needed for mRNA synthesis to occur in eukaryotic cells. These proteins 
include pol II and the general transcription factors that are required for transcription 
initiation at all genes; gene specific factors (activators and repressors) that help the 
transcription machinery to recognize the proper place for initiation of transcription 
(promoter) and initiate transcription; chromatin modifying and remodeling factors 
needed to make the chromatinized DNA template accessible for transcription factors 
binding and function; proteins that regulate the elongation; proteins required for 
processing of the primary transcript during elongation; and factors that stimulate 
transcription termination and help to transfer the transcript to the next step in the gene 
expression pathway.  
In this thesis, we will primarily focus on the mechanisms of transcription initiation and 
discuss the role of the multiprotein Mediator complex in transcription regulation.  
 
1.1 GENERAL TRANSCRIPTION MACHINERY. 
Pol II is the enzyme responsible for transcription of all nuclear, protein-encoding genes 
in the eukaryotic cell. Pol II initiates transcription at the promoter element located 
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immediately upstream of the gene. The core promoter is defined as sequence directing 
accurate initiation of transcription by pol II (Juven-Gershon & Kadonaga, 2010). 
Studies on eukaryotic promoters have identified a number of promoter elements. One 
of these elements, the TATA box, is normally situated 25-35 base pairs upstream from  
the transcription start site in higher eukaryotes and fission yeast, but 40-120 bp in 
budding yeasts. A number of other eukaryotic core elements have also been identified 
and characterized, including BRE (B Recognition Elements), Inr (Initiator), DPE 
(Downstream Promoter Element), MTE (Motif Ten Element) (Juven-Gershon & 
Kadonaga, 2010; Thomas & Chiang, 2006). Another type of cis-regulatory DNA 
sequences situated upstream of promoters is involved in transcriptional regulation. 
These regions, often referred as Upstream Activating Sequences (UAS) or enhancers, 
are targeted by DNA binding proteins (gene specific transcription factors) that control 
the levels (activation or repression) and timing of transcription (Fuxreiter et al, 2008).  
 
Pol II requires a set of additional general transcription factors to recognize a promoter 
and accurately start DNA dependent RNA synthesis. Pol II transcription starts with a 
controlled assembly on the core promoter of a set of transcription factors (TFIIB, D, E, 
F, and H) to form a so-called pre-initiation complex (PIC). These general transcription 
factors (GTFs) are not only needed for the promoter recognition, but also for promoter 
melting and the switch from the initiation stage to transcription elongation (Orphanides 
et al, 1996).  
First, the multi-protein TFIID complex via its TBP subunit (for TATA binding protein) 
recognizes and binds the TATA box causing a sharp DNA bend and thus creating a 
context for binding of other transcription factors. Next, TFIIB is recruited via its C-
terminal domain. TFIIB stabilizes the DNA/TFIID association, probably by assisting 
bending of DNA in the TBP-bound state and also recruits pol II via its N-terminal 
domain. Pol II might be either recruited alone or in association with TFIIF. Together, 
TFIID, TFIIB, and pol II form a minimal initiation complex that can transcribe a 3´-
tailed template. TFIIF provides a scaffold for TFIIE and TFIIH binding, and 
recruitment of these two factors completes PIC formation. The enzymatic activities of 
TFIIH are required for DNA unwinding as well as phosphorylation of the C-terminal 
domain of pol II (CTD), an event that is essential for transcription initiation.  
Stimulatory gene specific transcription factors (activators) bind to the promoter 
enhancer region, stimulate recruitment of the GTFs and pre-initiation complex 
assembly. In addition, there may be a need for factors that enable activator function, so 
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called co-activators, which may function as a bridge between activators and the general 
transcription machinery. 
 
1.1.1 RNA polymerase II 
Pol II is a large (more than 500 kD) multi-polypeptide complex composed of 12 
subunits, denoted from Rpb1 to Rpb12, which are highly conserved throughout the 
eukaryotes. The degree of similarity between human and S. cerevisiae pol II is so high 
that half of human pol II subunits (hRpb5, hRpb6, hRpb7, hRpb8, hRpb9, hRpb10) can 
function in place of their yeast counterparts in vivo. The two largest pol II subunits 
(Rpb1, Rpb2) share sequence homology with and are functionally related to subunits of 
the bacterial RNA polymerase. 
A number of pol II subunits (Rpb5, Rpb6, Rpb8, Rpb10, Rpb12) are shared with RNA 
polymerase I and RNA polymerase III. Only Rpb4, Rpb7, Rpb9 and the CTD of the 
Rpb1 subunit are unique to pol II. To understand the transcription mechanisms of pol II 
in molecular detail, the structure of this complicated machinery has been determined 
with X-ray chrystallography at atomic resolution. A model of S. cerevisiae pol II, 
lacking Rpb7 and Rpb4 was obtained in 2000 and 2001 (Cramer et al, 2000; Cramer et 
al, 2001) and revealed the subunit organization of pol II at 2.8 Å resolution. 
The two biggest subunits Rpb1 and Rpb2 form the core of the enzyme with smaller pol 
II subunits being situated on the periphery. The surface of the enzyme is mostly 
negatively charged apart from the positively charged central “cleft” that is built up by 
Rpb1 and Rpb2. The pol II active centre is situated at the floor of the cleft. Close to the 
active site is a protein density, named the “wall” that precludes the straight passage of 
the nucleic acid through the cleft, forcing it to bend at nearly a right angle. The 
structure of pol II has also been determined in its elongation state. Several different pol 
II structures have been determined and these are all very similar, with the only 
difference being a minor rotation of one side of the “cleft” towards another. This 
observation implies that the Rpb1 side of the cleft is mobile, capable of adopting 
different conformations. This mobile part was called the “clamp” and it was suggested 
to control DNA access to the active site.  
Indeed, the crystallization of the elongating form of pol II (in complex with a 3´-tailed 
DNA template) showed that the clamp swings more than 30 Å over the cleft upon DNA 
binding, adopting a “closed” conformation in the presence of a DNA-RNA hybrid 
during active transcription. Further studies of elongating pol II (on assembled in vitro 
  4 
DNA-RNA instead of transcribed), as well as a complex between pol II and TFIIB, 
shed light on the mechanism of DNA–RNA separation, how translocation is achieved 
during the elongation phase, how the transcription start site is selected, and details of 
the nucleotide selection mechanism, which ensures fidelity during transcription. Later, 
the structure of the complete 12 subunit pol II complex (including the Rpb4 and Rpb7 
subunits) has also been resolved. The Rpb4-Rpb7 heterodimer binds to core pol II near 
the base of the clamp, forcing the clamp to adopt the closed conformation, similar to 
that seen in the elongating polymerase. The Rpb4/7 dimer was suggested to assist 
transcription pre-initiation complex assembly, stabilizing TBP-TFIIB bound promoters, 
and increasing the pol II upstream interaction face of pol II (Bushnell & Kornberg, 
2003; Kornberg, 2007).  
Recently the crystal structure of pol II isolated from another eukaryote, fission yeast, 
has been resolved revealing an overall similarity, but also interesting differences in 
structure between the two yeasts, e.g. in the regions proposed to interact with TFIIB, 
TFIIF and TFIIH transcription factors (Spåhr et al, 2009) 
 
 
1.1.1.1 C-terminal domain of RNA polymerase II 
The largest subunit Rpb1 has a unique CTD wich has a tandem repetitive structure of 
characteristic heptapeptide sequence (Y1S2P3T4S5P6S7) with the number of repeats 
depending on the complexity of the organism and varying from 26 (27) in yeasts to 52 
in humans (Allison et al, 1985; Corden et al, 1985a). CTD is crucial for life as has been 
shown for different organisms. Truncation of CTD by 20 repeats was deleterious to 
mouse pol II function (Bartolomei et al, 1988). Similarly, in S. cerevisiae cells 
shortening of the CTD to less than eight heptades led to cell death, whereas pol II 
containing 10 repeats grew essentially as WT albeit with sensitivity to high and low 
temperatures (Nonet et al, 1987).  
The tandem structure of the repetitions also seemed to be important, as strains with 
insertion of alanines stretches between the repetitive heptads were inviable (Stiller & 
Cook, 2004; Stiller & Hall, 2002). However, in vitro studies of various purified forms 
of pol II have argued against the absolute necessity of the CTD for transcription, since 
proteolytic derivative of Drosophila (Zehring et al, 1988), budding yeasts (Myers et al, 
1998) and human (Dahmus & Kedinger, 1983) pol II lacking CTD were still able to 
transcribe RNA from some promoters in cell-free systems. This discrepancy in data 
was the first indication of CTD importance for interaction with other proteins, perhaps 
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controlling pol II interactions with co-activators during initiation or serving as a 
docking site for additional accessory proteins in order to assist transcription, rather than 
itself playing a role in the enzymatic activity of pol II. 
Another important feature of the CTD is that almost all amino residues of the repeats 
can be subjected to various post-translational modifications, such as phosphorylation, 
glycosylation or proline isomerization. CTD phosphorylation is the most well studied 
of the post-translational modifications and it has been shown to play a role in different 
aspects of transcription, including co-activator interactions, nascent mRNA processing, 
regulation of DNA accessibility etc. Post-translational modifications of CTD came into 
view when three subspecies of pol II, designated IIA, IIB, and IIO were purified from a 
number of eukaryotic organisms (Schwartz & Roeder, 1975),(Corden et al, 1985b). 
Within one organism these forms seemed to differ only by the weight of their largest 
subunit, which migrated differently in SDS-PAGE analysis. Pol IIB later turned out to 
represent a product of proteolytic CTD degradation in the course of purification, and 
this form is thus not physiologically relevant in vivo. Pol IIO has been identified as pol 
II with a hyperphosphorylated CTD, whereas pol IIA is hardly phosphorylated at all. 
The observed phosphorylation is biologically relevant since substitution of 
phosphorylated amino acids gives rise to a lethal phenotype (West & Corden, 1995; 
Yuryev & Corden, 1996). The observation of differently phosphorylated states of pol II 
stimulated attempts to elucidate the functional differences between these isoforms.  
Although 5 potential phosphorylation sites are present in the consensus sequence, Ser2 
and Ser5 are the amino residues that are preferentially phosphorylated in vivo. Several 
CTD phosphorylating kinases have been identified to date including the TFIIH 
component Cdk7, the Mediator component Cdk8, as well as the transcription 
elongation factor b (p-TEFb, Cdk9) (Cho et al, 2001; Hengartner et al, 1998; 
Komarnitsky et al, 2000). These kinases are all conserved in evolution and orthologues 
have been identified in many eukaryotes, including yeast and mammals. The Cdk7 
subunit of TFIIH is the major CTD kinase responsible for Ser5 phosphorylation. 
Immunofluorescence studies investigating the distribution of hyperphosphorylated pol 
II in Drosophila polythene chromosome revealed pol IIO localization to actively 
transcribing puffs, suggesting that pol IIO represents the elongating form of the 
polymerase (Weeks et al, 1993). On the other hand only the non-phosphorylated form 
of pol II can interact with general transcription factors upon pre-initiation complex 
formation (LU et al, 1991), whereas phosphorylation of CTD prevents pol II entry into 
the pre-initiation complex. 
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The CTD of pol II thus undergoes a cyclic pattern of phosphorylation and 
dephosphorylation during the course of transcription (Figure 1) (Egloff & Murphy, 
2008). 
 
Figure 1. Modification of the pol II CTD heptapeptide during transcription of protein coding genes. 
Reprinted from Trends Genet, vol. 24 (6), Egloff and Murphy, Cracking the RNA polymerase II CTD 
code, pp.280-8, Copyright (2008), with permission from Elsevier. 
 
First, non-phosphorylated pol II enters the PIC. After CTD phosphorylation by Cdk7 
transcription is initiated. When pol II switches to active elongation, Ser2 is 
phosphorylated by p-TEFb. CTD phosphorylation plays an important role in the 
coordination of transcription elongation and mRNA processing. Ser2 phosphorylation 
is primarily located in the body of the gene and the modification is necessary for the 
switch to productive elongation. Phospho-Ser5 is reported to serve as a mark for 
recruiting mRNA capping enzymes. Chromatin immunoprecipitation data shows co-
localization of both the Ser5-phosphorylation mark and guanilyltransferase enzymes at 
the 5′ -end of transcribed genes (Komarnitsky et al, 2000; Morris et al, 2005; Schroeder 
et al, 2000) and the capping enzymes have been shown to bind directly to CTD 
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hyperphosphorylated at position Ser5 in vitro (McCracken et al, 1997). The recruitment 
of capping enzymes is dynamic and Ser5-phosphorylation dependent. (Schroeder et al, 
2000).  
S. pombe p-TEFb (Pch1/spCdk9) interacts with the 5′ capping methyltransferase Pcm1 
and forms a near stoichiometric complex. Ser2 phosphorylation as well as p-TEFb 
recruitment to chromatin is abolished upon Pcm1 depletion, and ChIP analysis shows 
that Pcm1 and spCdk9 co-localize in vivo (Guiguen et al, 2007). Later experiments 
demonstrated that Cdk7 dependent phosphorylation is necessary and sufficient to 
promote recruitment of Cdk9-Pcm1 complexes (Viladevall et al, 2009). Moreover, in 
vitro analysis demonstrated that the Cdk7 kinase can “prime” the CTD for Cdk9 
dependent phosphorylation. These findings suggest a checkpoints mechanism for 
transcription elongation, allowing and stimulating Ser2 phosphorylation and 
transcription elongation only if the mRNA molecule has been properly capped. In 
addition, in S. cerevisiae Cdk7/Kin28 and Ctk1 dependent phosphorylation of the CTD 
is needed to suppress cryptic transcription at active genes.  
Factors involved in mRNA 3′-end processing bind directly to phospho-CTD, in both 
mammals and yeasts (Ahn et al, 2004; Buratowski, 2005; Hirose & Ohkuma, 2007). 
Recently, Ser7 has been identified as an important phosphorylation site on pol II CTD. 
TFIIH phosphorylates Ser7 and the modification has been linked to processing of pol II 
transcribed spliceosomal snRNAs in mammalian cells (Akhtar et al, 2009). 
Thus, modifications of pol II CTD, including phosphorylation, have complex and 
multiple functions at all steps of the transcription process (Belotserkovskaya & 
Reinberg, 2004).  
Genome-wide studies in Drosophila (Muse et al, 2007) as well as in human embryonic 
stem cells (Guenther et al, 2007) have shown that pol II is stalled soon after 
transcription initiation at nearly 20% of promoters (including heat shock promoters, but 
also at constitutively expressed genes). Negative elongation factor (NELF) is required 
for pausing to occur and immunodepletion of this factor leads to a re-distribution of pol 
II from promoter proximal positions into the bodies of the open reading frames (ORFs). 
Escape of pol II poised in this way into processive elongation provides an alternative 
way to regulate mRNA synthesis in metazoan cells in response to environmental 
stimuli. This switch can be a rate-limiting step of transcription, rather than the 
transcription initiation reaction itself.  
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1.1.2 TFIID 
TFIID is the transcription factor that starts PIC assembly by binding to DNA. It is a 
massive multiprotein complex with a total molecular weight of about 750 kDa, 
consisting of TBP and multiple TBP associated factors (TAFs). TFIID was first isolated 
by purification of an activity from human cell extracts that was necessary for 
transcription in vitro. One polypeptide of the complex, namely TBP, has been shown to 
be a major factor responsible for TATA box binding activity of TFIID in yeast, fruit 
fly, and mammals (Orphanides et al, 1996). TBP can also support transcription 
initiation on TATA containing promoters in the absence of TAFs, in a cell free 
transcription system. At least 14 TAFs have been identified in humans and most of 
them are highly conserved from yeasts to mammals. Thirteen TAF-encoding genes are 
essential in S. cerevisiae (Tora, 2002) and TAFs are not exclusively restricted to TFIID, 
but can also be part of other coactivators, e.g. SAGA and the SAGA-like complex. 
TFIID can act as a co-activator complex and human TFIID has been shown to interact 
with a number of transcriptional activators via its Taf7 subunit, whereas D. 
melanogaster TFIID can bind the Sp1 activation domain. TAF1, the largest subunit of 
TFIID, has histone acetyltransferase (HAT) activity and might therefore change 
chromatin structure. Indeed, TFIID, but not TBP alone, is required for pol II 
transcription from a pre-assembled chromatin template in vitro (Wu et al, 1999). 
The crystal structure of the TBP/DNA complex has been solved from a number of 
different species and the molecular details are highly conserved. The TATA box is 
recognized by the C-terminal part of TBP, which displays 80% identity between yeast 
and human TBP and is often referred to as core TBP. The N-terminal part of TBP is 
variable both in length and sequence and is dispensable for DNA binding. This region 
appears to play a regulatory role, since it can inhibit the binding of core TBP to the 
TATA box. 
The current view on TFIID function is that it binds to core promoters for both TATA-
promoters and TATA-less promoters, works as a co-activator for transcription, either 
by directly recruiting pol II or by modifying either chromatin or other proteins involved 
in transcription(Thomas & Chiang, 2006).  
 
1.1.3 TFIIB 
TFIIB is a single polypeptide transcription factor that performs critical functions in 
promoter recognition, since it stabilizes the TPB-TATA complex, stimulates pol II 
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recruitment and directs transcription start site selection. The protein was originally 
purified from HeLa cells as a factor necessary to tether pol II to TBP-DNA complex 
(Reinberg & Roeder, 1987). The C-terminal domain of TFIIB is composed of 10 α-
helixes forming two imperfect direct repeats of 5 helices each (Tsai & Sigler, 2000). 
TFIIB core is more resistant to proteolytic degradation and has been shown to bind to 
the carboxy-terminal domain of TBP (Barberis et al, 1993), and also to interact with 
DNA both upstream and downstream of the TATA-box (in a sequence independent 
manner) (Nikolov et al, 1995). However TFIIB can also make sequence dependent 
DNA contacts in the absence of TBP at the B-recognition elements in the promoter 
region. 
The N-terminal part of TFIIB contains a cysteine rich sequence, forming a Zn ribbon 
motif. X-ray crystallography studies of TFIIB in complex with pol II have shown that 
the Zn ribbon motif is involved in interactions with Rpb1 and Rpb2 at the pol II dock 
domain (Bushnell et al, 2004). This finding is in agreement with the observation that 
mutations of cysteine residues in the Zn ribbon as well as deletions in the N-terminal 
part of TFIIB, abolish TFIIB-pol II interactions (Buratowski & Zhou, 1993; Deng & 
Roberts, 2007). The region of TFIIB, called the B-finger motif, is located immediately 
after the ribbon domain. A number of mutations in “finger tip” residues have been 
shown important for transcription start site selection (Zhang et al, 2002). X-ray 
structure analyses of TFIIB/pol II and pol II/DNA/RNA elongating complexes have 
revealed that the B-finger projects into the active center of pol II close to the DNA 
template strand and possibly interferes with nascent RNA.  
 
1.1.4 TFIIF.  
Transcription factor IIF (TFIIF) consists of three subunits in budding yeast (Tfg1, Tfg2, 
and Tfg3) and two subunits (RAP74 and RAP30) in higher eukaryotes (Thomas & 
Chiang, 2006). The two larger subunits in the yeast complex (Tfg1 and Tfg2) are 
essential, and homologous to RAP74 and RAP30 respectively (Henry et al, 1994). 
TFIIF is important for transcription initiation and indispensable for TFIIE and TFIIH 
recruitment (Orphanides et al, 1996), as well as transcription elongation (Rap74 is 
required for stimulation of the pol II elongation rate). Rap74 is also involved in pol II 
recycling, promoting CTD dephosphorylation by the Fcp1 phosphatase (Chambers et 
al, 1995). 
  10 
Studies in yeasts have shown that mutations in both TFG1 and TFG2 can cause 
changes in transcription start site utilization. Moreover, TFG1 mutations functionally 
interact with mutations in TFIIB, TFG2, and RPB9 (Ghazy et al, 2004). 
Photocrosslinking experiments have mapped the TFIIF-pol II interaction to the Rpb2 
lobe and protrusion domains via TFIIF dimerization domain (Chen et al, 2007). This 
observation implies that the pol II-TFIIB-TFIIF interaction is a determinant for 
transcription start site selection.  
 
1.1.5 TFIIE 
Transcription factor IIE (TFIIE) is composed of two subunits, which in human TFIIE 
form a tetramer. In S. pombe, both the genes encoding TFIIEα and TFIIEβ are essential 
for viability and a number of functional domains and motifs have been characterized in 
the two proteins. TFIIE binds to promoter DNA approximately 10 bp upstream of 
transcription start sites and interacts directly with pol II, TFIIB, and TFIIF (Forget et al, 
2004). TFIIE also binds directly to TFIIH and stimulates its kinase activity towards the 
CTD (Ohkuma & Roeder, 1994). Recent photocrosslinking studies of the initiation 
complex have mapped TFIIE to the Rpb1 clamp domain, on the opposite side of the 
cleft from the TFIIF binding site (Chen et al, 2007). 
 
1.1.6 TFIIH 
TFIIH is the most complicated of the basal transcription factors and harbors a number 
of distinct enzymatic activities. TFIIH was initially identified as 9 subunit complex that 
could be separated into two subcomplexes: the core TFIIH (containing 6 subunits) and 
the cyclin activated kinase (CAK) subcomplex (also referred as to TFIIK), containing 
the cyclin H (CycH), cyclin dependent kinase 7 (Cdk7) pair together with the accessory 
subunit Mat1. Core TFIIH contain two helicases (XPD and XPB) with opposite 
polarity in their DNA unwinding activities. XPB is a 3′ to 5′ helicase and its helicase 
activity is needed for both transcription initiation for promoter clearance and DNA 
repair. XPD is a 5′ to 3′ helicase, which is mainly needed for DNA repair, playing 
merely a structural role in transcription, being the intermediate subunit that connects 
core TFIIH with the CAK subcomplex (Thomas & Chiang, 2006).  
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1.2  CHROMATIN 
 
The mechanism described above for transcription initiation does not reflect the 
complexity of the in vivo situation, since the basal transcription machinery has to act in 
the context of limited access to DNA within living eukaryotic cells. 
 
1.2.1 Nucleosome 
Eukaryotic DNA within the cell has to be tightly packed to fit into nucleus. This is 
achieved by its organization into a nucleoprotein complex together with architectural 
proteins called histones, thus forming the so-called chromatin structure. Histone-DNA 
association not only helps to pack long DNA molecules to fit into the cell, but confers 
an additional intrinsic level of regulation making underlying DNA less accessible for 
processes such as DNA transcription, replication, repair etc. 
The primary unit of chromatin, the nucleosome core particle, consists of an octamer 
with two copies of each core histone (H2A, H2B, H3 and H4) with 146 bp of double 
stranded DNA wrapped around them in approximately 1.7 turns (Figure 2) (Luger et al, 
1997). Histones are very conserved basic proteins. Core histones have a globular 
histone fold domain that is crucial for nucleosome formation and unstructured N-
terminal or C-terminal histone “tails”, protruding from the nucleosome core, which are 
important for further packaging into chromatin. The intervening linker DNA found 
between nucleosome particles can vary in length and makes up the chain of 
nucleosomes. The “beads on a string” structure can be further compacted into more 
dense higher order structures. Even packaging into a single nucleosome unit 
significantly reduces the accessibility of the DNA compared to nucleosome-free naked 
DNA and hence prevent potential transcription factors from DNA-binding. 
Nucleosomes, therefore act as general gene repressors. Regulation of transcription must 
consequently include correct temporal/spatial changes in the chromatin environment in 
response to external signals.  
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Figure 2. Structure of a nucleosome particle from the front (left) and from the side (right). DNA 
backbones (brown and turquoise) are wrapped around histone octamer. Histone protein chains are shown: 
H3-blue; H4-green; H2A-yellow; H2B-red. Reprinted by permission from Macmillian Publishers Ltd: 
Nature, Luger et al., copyright 1997 
 
 
1.2.2 Heterochromatin and Euchromatin  
Two forms of chromatin are traditionally distinguished. Heterochromatin that is more 
tightly packed throughout cell cycle is generally considered as non-permissive for 
transcription and associated with transcriptional silencing. In euchromatin, on the other 
hand, DNA is more loosely packaged and therefore more accessible for binding by 
transcription factors and activators, although euchromatic regions are not necessarily 
actively transcribed at all times. Both the heterochromatin and euchromatin structures 
are quite dynamic and transiently modulated.  
 
1.2.3 Chromatin remodeling 
During the last years the role of chromatin in the regulation of eukaryotic gene 
transcription has been studied in great detail. Several ways of regulating chromatin 
structure have been described and these include: 
a) ATP dependent chromatin remodeling (sliding or eviction of nucleosomes or 
parts of nucleosomes by factors utilizing energy from ATP hydrolysis) 
  13 
b) Use of covalent posttranslational modifications on histone tail residues to 
change the density of nucleosome packaging. Those modifications are often 
concerted with ATP dependent chromatin remodeling  
c) ATP dependent replacement of the canonical histones with alternative histone 
variants that alter the stability of a nucleosome and confer specific properties to 
surrounding chromatin. Variant histones are often targeted to specific positions. 
H2A.Z is associated with promoter regions and is thought to promote 
transcription (Cairns, 2009); H2A.Z containing nucleosomes can be less stable 
than nucleosomes composed of canonical histones and therefore more easily 
displaced or evicted upon activation of transcription  
d) DNA methylation  
A large number of chromatin remodeling complexes that act as co-activators and co-
repressors have been described and shown to function via diverse mechanisms that can 
rearrange chromatin structure in response to specific stimuli (Clapier & Cairns, 2009). 
 
1.2.4 Posttranslational histone modifications and histone code 
The N-terminal histone tails can be modified at numerous residues (K, R, S). A variety 
of posttranslational modifications, such as acetylation, methylation, ubiquitination, 
sumoulation and phosphorylation etc. have been described in the literature (Kouzarides, 
2007) (Figure 3). Acetylation and methylation of specific lysines and arginines have 
attracted the most attention and are best studied. Lysines can be acetylated at position ε-
N by histone acetyltransferases (HAT) or methylated by histone methyltransferases 
(HMT), leading to mono-, di-, or tri-methylation. Acetylation and methylation are 
reversible and can be removed by histone deacetylases (HDAC) or histone 
demethylases (HDM). The chemical consequences of covalent modifications differ as 
the Ac group is negatively charged, which causes a change of the charge of the 
respective lysine, while transfer of a methyl group does not. In addition, several histone 
residues in the same nucleosome (not necessarily on the same histone tail) can be 
modified at the same time creating a particular pattern of modifications. Analysis 
predominantly of histone methylation and acetylation at ε-N of lysines revealed that 
particular histone modification could correlate with active or repressed chromatin. 
Methylation of H3K4 (Santos-Rosa et al, 2002) and general histone acetylation 
coincide for instance with actively transcribed locations, whereas H3K9, H3K27 and 
H4K20 methylation are linked to silenced loci (Ruthenburg et al, 2007). Moreover, 
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genome wide chromatin immunoprecipitation studies have demonstrated that 
euchromatin assigned H3K4 methylation and heterochromatin localized H3K9 
methylation are mutually exclusive (Lachner et al, 2004). These observations led to the 
hypothesis of a “histone code”, suggesting that particular patterns of modification 
dictate the establishment of a certain chromatin environment. These modifications 
sometimes can be passed on to the daughter cell, thus generating an epigenetic 
memory. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Genome compaction and histone modifications. Reprinted from Essay in Biochemistry. Bou 
Kheir T. and Lund A.H., Epigenetic dynamics across the cell cycle, Essays Biochem.(2010) 48, 107-
120 the Biochemical Society  
 
Histone modifications have been studied using mainly two approaches. First, the 
overall distribution of a particular modification can be assessed genome wide using 
ChIP-chip methodology. Even if this approach has generated a wealth of information 
about average modification status of the cell population, it does not give much insight 
about the palette of modifications within a single nucleosome. To address this question 
mass-spectrometry is nowadays often used (Young et al, 2009). 
Histone acetylation often promotes transcription and many transcriptional co-factors 
and activators possess HAT activities, e.g. GCN5 and p300/CBP. Two different, but 
not mutually exclusive, models resulted from the analysis of correlations between 
modification and transcriptional state and explain how histone modifications can affect 
DNA accessibility. First, reversible histone acetylation (or phosphorylation) can simply 
modulate a net charge of the nucleosome, thereby altering electrostatic interactions 
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between histones and negatively charged DNA. Second, histone modifications (both 
methylation and acetylation) can induce a cascade of events, resulting in chromatin 
remodeling. The modifications are recognized and bound by specific protein domains, 
e.g. chromodomains or plant homeodomains (PHD) recognize methylated histones, 
whereas bromodomains interact with acetylated histone tails. This type of effector 
proteins that recognize specific histone modifications, in turn promote recruitment of 
chromatin modifying complexes that shape chromatin and thus assist either gene 
silencing or activation.  
Even if the histone code hypothesis suggests that there is a simple, linear correlation 
between modifications and transcriptional activity, this is not always the case in vivo. 
Broad correlations observed on the genome wide level can often be difficult to observe 
at individual genes. In addition, different modifications may functionally interact in 
complex and unpredictable manners. In murine ES cells the specific pattern of 
«bivalent» simultaneous H3K4 and H3K27 histone methylation (previously thought not 
to be coinciding) has been described for the genes related to early differentiation that 
are normally silent in stem cells (Azuara et al, 2006; Bernstein et al, 2006). Only genes 
containing solely H3K4 methylation are actively transcribed, while regions associated 
with bivalent marks are held repressed “primed” or “poised” for subsequent instant 
activation upon early development. Later it was shown that H3K27 methylation in 
human (and murine) ES is very often followed by H3K4 methylation and thousands of 
genes have both marks simultaneously (Mikkelsen et al, 2007; Pan et al, 2007; Zhao et 
al, 2007). In the course of differentiation either the repressive or activating mark is 
removed and the gene is induced or remain silent, thus providing yet another possible 
mechanism of transcriptional control. This feature is not unique to stem cells since 
bivalent marks were found at some pluripotency-associated transcription factors 
(NANOG, SOX2) in cells induced for differentiation (Pan et al, 2007). 
 
1.2.5 ATP dependent remodeling 
Specific enzymes can utilize energy derived from ATP hydrolysis to alter chromatin 
structure. These factors can participate in actively sliding (moving histone octamer 
along DNA), loading, ejecting (displacing histone octamers from DNA), disrupting 
(e.g. removal of H2A-H2B dimers) or restructuring nucleosomes (e.g. exchanging 
canonical H2A-H2B dimers with ones containing histone variants) (Cairns, 2005). All 
the ATP-remodelers, whether they are single subunit enzymes or larger multiprotein 
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complexes, contain a catalitic subunit that belongs to the Snf2 family of the SF2 
superfamily of ATPases (Clapier & Cairns, 2009).  
 SWI/SNF –the protein that gives the name to the family of ATP-remodelers- was first 
identified in budding yeasts in screens for genes regulating mating type switching 
(SWI) and involved in sucrose fermentation (Sucrose Non Fermenting)(Sudarsanam & 
Winston, 2000)). Later other members of the Snf2 family were identified based on 
sequence similarity in the ATPase domain. The characteristic feature of Snf2 family 
proteins is conserved region including 7 helicase-related motifs similar to DExx box 
helicases, although no intrinsic helicase activity has been reported. Comparison to 
strand-separating enzymes reveals that Snf2 family proteins lack the motif needed to 
detach the two strands from one another, so the enzymes are in fact translocases and not 
helicases (Dürr et al, 2006). 
The Snf2 family proteins can be classified into subfamilies in two different ways. A 
more traditional classification is based on the additional functional domains adjacent to 
the helicase like domain within the ATPase subunit (Clapier & Cairns, 2009; Ho & 
Crabtree, 2010; Saha et al, 2006). Depending on conserved sequence motifs flanking 
the ATPase domain, these ATP-remodelers are divided into the following subfamilies: 
SWI2/SNF2, ISWI, CHD1 and INO80. The ATPases of the SWI/SNF family contain 
an N-terminal helicase SANT-like domain together with a C-terminal bromodomain 
(Horn,Peterson 2001) that can recognize acetylated histones; members of the CHD1 
family contain double tandem N terminal chromodomains; ISWI family proteins are 
characterized by a SANT domain adjacent to a SLIDE domain, both functioning 
together as a histone-binding module. Accessory motifs within associated subunits 
often control the activity of the remodeling complexes or help to determine the 
targeting of these activities to specific genomic locations. 
Another way to classify these proteins is based solely on the sequence comparison of 
conserved helicase like domain in Snf2 family proteins throughout all eukaryotes 
(Flaus et al, 2006). All ATP remodelers share some common features: apart from DNA 
affinity, they also possess affinity to nucleosomes, hydrolyze ATP and possess a DNA 
dependent ATPase activity that breaks DNA-nucleosome contacts. One nucleosome 
forms 14 contacts with surrounding DNA that have to be broken, not necessarily 
simultaneously, to move the nucleosome on DNA. 
The CHD branch is conserved from S. cerevisiae to mammals with one ortholog in 
budding yeasts, two in fission yeasts and 9 in humans (Jae Yoo et al, 2002; Marfella & 
Imbalzano, 2007; Woodage et al, 1997).  
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The signature motifs of CHD remodelers are N-terminal double chromodomains 
(Woodage et al, 1997), implied to play a role in chromatin targeting. This group is 
further subdivided into subgroups depending on the presence of additional sequence 
motifs. Mammalian CHD1 and CHD2, as well as ScChd1, SpHrp1 and SpHrp3 fall 
into the same subgroup, having an C-terminal DNA binding domain that binds 
preferentially to A/T rich sequences (Stokes & Perry, 1995). Chd1 proteins are 
implicated in pol II transcription elongation in a range of eukaryotes. For instance 
dCHD1 is localized to the highly transcribed regions (puffs) of polytene chromosomes 
in a pattern highly similar to elongating pol II (Stokes et al, 1996). Both S. pombe 
hrp1Δ and S. cerevisiae chd1Δ are deficient in transcription termination (Alén et al, 
2002). Human CHD1 binds selectively to H3K4-Me mark via double chromodomains 
in vitro (Sims et al, 2005). Chd1 can play multiple roles in chromatin remodeling. Chd1 
proteins have been suggested to play a role in transcription coupled nucleosome 
disassembly, primarily at the transcription start site (Walfridsson et al, 2007) as well as  
to act as a chromatin assembly factor both in vitro and in vivo (Konev et al, 2007; 
Lusser et al, 2005; Walfridsson et al, 2005).  
 
1.3 MEDIATOR AND ITS ROLE IN TRANSCRIPTION. 
1.3.1 Discovery of the Mediator 
The over-expression of the Gal4 activator leads to reduced expression of genes, lacking 
the respective binding site (Gill & Ptashne, 1988), however the sequestering of Gal4 by 
the co-expression of Gal80, which binds Gal4 activating domain, can partially restore 
expression. Similarly, expression of the activating domain of the viral transcriptional 
activator VP-16 causes a significant decrease in expression of unrelated gene. Hormone 
dependent transcription factors can also affect expression of each other’s target genes in 
HeLa cells–an indication that the amount of transcription factors might be limited 
(Meyer et al, 1989). This effect of inhibition by unrelated activator suggested that 
different activators might compete for a particular intermediary factor that conveys 
their enhancer function on transcription and is common for various activators. 
Furthermore, in vitro transcription experiments using partially purified yeast proteins 
have shown that polymerase II assisted by basal transcription factors could produce 
RNA from naked (not nucleosomal) DNA template but was unable to respond to the 
addition of an activator (Flanagan et al, 1991; Kelleher et al, 1990). Together, these 
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observations suggested the existence of a co-activator complex that could interact with 
activators and stimulate the activity of the general transcription machinery. 
 
 Attempts to isolate the missing component that could restore the ability to stimulate 
activator-dependent transcription in vitro led to the discovery of a large protein 
complex named Mediator (Kim et al, 1994). Mediator thus is a multiprotein complex 
that can convey information from activators to basal transcription machinery. 
Mediator has been purified as a holoenzyme with RNA polymerase II and TFIIF (Kim 
et al, 1994). It is required for transcription of virtually all pol II dependent genes since 
the mutation of the essential Mediator subunit and mutation of the largest pol II subunit 
Rpb1 had similar consequences for gene expression (Holstege et al, 1998).  
Some of budding yeast Mediator subunits were independently identified in genetic 
screens for suppressors of Ty insertion in S. cerevisiae (Thompson et al, 1993; 
Yamaguchi et al, 2001), as well as for suppressors of cold sensitivity caused by pol II 
CTD truncation (Nonet & Young, 1989),(Koleske et al, 1992), which implied their 
functional relation to the CTD and their importance for RNA polymerase II 
transcription. All but four Suppressors of RNA polymerase B mutations (Srb) proteins 
were identified as subunits of transcriptionally active Mediator complex. 
The four subunits Srb8, 9, 10 and 11 were isolated as a separate complex in budding 
yeasts (Borggrefe et al, 2002). Nevertheless, the results of Hengartner (Hengartner et al, 
1995) suggested that Srb8-11 could associate with Mediator and other components of 
the pol II transcription machinery in vivo.  
Mediator components were also identified as positive transcriptional regulators 
(Carlson, 1997). A Gal11/Med15 mutation reduced transcription of enzymes involved 
in galactose catabolism (encoded by Gal1, 7, 10) to at least 30% of the wild type level 
upon galactose induction. The effect was not connected to diminished amounts of Gal4, 
suggesting that Gal11/Med15 was required for mediating the in vivo response to the 
Gal4 transcription factor (Suzuki et al, 1988). 
Several similar Mediator-like co-activator complexes were purified from human and 
murine cells in different labs, based either on their affinity to known transcriptional 
activators (factors) (Fondell et al, 1996; Näär et al, 1999; Rachez et al, 1998), or to 
CTD (Jiang et al, 1998; Näär et al, 1999), their activity in in vitro transcription 
(Kretzschmar et al, 1994), or based on homology to known yeast Mediator 
components.  
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TRAP/SMCC (Gu et al, 1999; Ito et al, 1999), DRIP (Rachez et al, 1998), ARC-L, 
CRSP (Ryu & Tjian, 1999; Ryu et al, 1999), NAT (Sun et al, 1998), PC2 (Kretzschmar 
et al, 1994)- all these complexes turned out to represent metazoan Mediators.  
Mammalian Mediator–like complexes include large 1-2 MDa complexes such as 
TRAP/SMCC, ARC-L, mouse and rat Mediators as well as smaller, around 500-700 
kDa complexes including CRSP, Positive Cofactor PC2. The composition of those 
complexes varied significantly and only a subset of polypeptides was found in nearly 
all Mediator preparations. The variety of subunit composition could reflect the 
existence of distinct Mediator assemblies with varying transcriptional behavior. 
 
The primary difference in the composition between Small(S-) and Large(L-) Mediator 
complexes was the absence or presence of a four subunit kinase subcomplex composed 
of Med13/Trap240, Med12/Trap230, Cdk8 and Cyclin C (Paper I). Systematic analysis 
using Multidimentional protein identification technology (MudPIT) by Sato et al. 
addressed the subunit composition of Mammalian Mediator-like complexes. 30 
Mediator components previously reported by others were identified in this study along 
with two new polypeptides previously not reported as components of Mediator like 
complexes (Sato et al, 2004).  
 
Primary sequence conservation between yeast and mammal Mediator subunits is not 
obvious for the majority of subunits. Only eight Mediator subunits were at first 
acknowledged to be evolutionary conserved in eukaryotes (Malik & Roeder, 2000) and 
it was initially questioned if Mediator really was a evolutionary conserved entity. 
Intensive cross-species sequence comparisons studies from different labs in 
combination with biochemical observation allowed detection of metazoan homologs 
for nearly all yeast Mediator subunits, therefore unified nomenclature for Mediator 
subunuts was proposed (Table1) (Bourbon et al, 2004). 
 
1.3.2 Modular structure of Mediator complex 
The first view on the Mediator was given by electron microscopy single particle 
analysis of S. cerevisiae Mediator at low resolution (40Å) (Asturias et al, 1999). It 
revealed that purified Mediator has a compact globular structure, but in the presence of 
pol II a fraction of Mediator can bind to the enzyme and adopt a fully extended 
conformation “embracing” globular polymerase and forming a holoenzyme. In this 
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conformation three different domains of Mediator could be distinguished on the image. 
The biggest module was denoted the head domain, followed by the middle and the tail 
domains. Interestingly, Mediator was unable to form a stable association with CTD-less 
pol II, suggesting that this structure is required for holoenzyme formation. Pol II 
appeared to form multiple contacts with Mediator via its head and middle domain, 
while the tail domain remained free in solution (Asturias et al, 1999; Dotson et al, 
2000).  
 
Early biochemical analysis of the S. cerevisiae Mediator-complex also implied a 
modular organization of Mediator. Urea dissociation analysis of immobilized purified 
Mediator (Lee & Kim, 1998), analysis of subunit composition of Mediators from 
deletion strains for known subunits (Myers et al, 1999), in vitro reconstitution 
combined with immunoprecipitation experiments (Kang et al, 2001), as well as two 
hybrid-screen data (Guglielmi et al, 2004) enabled a detailed characterization of the 
polypeptides organization within the complex and suggested that it was constructed 
from smaller subcomplexes. All these data combined with transcriptional profile 
analysis in deletion strains for non-essential subunits in S. cerevisiae supported an 
organization of subunits into specific subcomplexes (van de Peppel et al, 2005).  
Nowadays the subunit organization for at least budding yeasts Mediator is well 
established. 
1.3.2.1 The head module 
The head module is critical for Mediator function. First, the Med17 subunit is crucial 
for expression of almost all pol II transcribed genes. Inactivation of the head module 
leads to impaired recruitment of Mediator to at least some promoters (Takagi et al, 
2006) and most head module subunits are conserved in higher eukaryotes (Bourbon et 
al, 2004). EM pictures of the pol II- holoenzyme revealed that the head module formed 
extensive contacts with pol II (Dotson et al, 2000). All but 2 subunits of head module 
(Med18 and Med20) are essential for cell viability.  
 Using the baculovirus expression system, it was possible to co-express and reconstitute 
a full 7 subunits head module. It was composed of the Med6, 8, 11, 17, 18, 20 and 22 
subunits (Takagi et al, 2006). Further EM single particle analysis revealed that the head 
module was organized around a three subunit compact core, comprised of Med11, 17, 
and 22 (Cai et al, 2010). Med6 and Med8 subunits form the proximal end of the head 
module structure serving as an interacting surface with the rest of Mediator. Med6 is 
suggested to bridge the middle and core modules, by directly interacting with Med21. 
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Table 1. Mediator complex subunits. 
 S. cerevisiae Module S. pombe H. sapiens Essential  
Med1 Med1 M Pmc2 
TRAP220, CRSP200 
ARC/DRIP205 
N 
Med2 Med2 T   N 
Med3 Pgd1/Hrs1 T   N 
Med4 Med4 M Pmc4/Med4 TRAP/DRIP36 Y 
Med5 Nut1 T   N 
Med6 Med6 H Pmc5 hMed6, DRIP33 Y 
Med7 Med7 M Med7 
hMed7, DRIP34, 
CRSP33 
Y 
Med8  H Med8/Sep15 ARC32 Y 
Med9 Cse2/Med9 M  Med25 N 
Med10 Nut2/Med10 M Nut2 hNut2, hMed10 Y 
Med11 Med11 H  HSPC296 Y 
Med12 Srb8 K Srb8 
TRAP230, 
ARC/DRIP240 
N 
Med12L    TRALPUSH  
Med13 Ssn2/Srb9 K Trap240 
TRAP240, 
ARC/DRIP250 
N 
Med13L    PROSIT240  
Med14 Rgr1 M/T Pmc1 
TRAP170, 
ARC/DRIP150 
Y 
Med15 Gal11/Spt13 T Med15 ARC105, PCQAP N 
Med16 Sin4 T  TRAP95, DRIP92 N 
Med17 Srb4 H Srb4 
TRAP80, 
ARC/DRIP77 
Y 
Med18 Srb5 H Pmc6/Sep11 P28b N 
Med19 Rox3 H Rox3 LCMR1 N 
Med20 Srb2 H Med20 hTRFP N 
Med21 Srb7 M Srb7 hSrb7 Y 
Med22 Srb6 H Srb6 Surf5 Y 
Med23    
ARC/DRIP130, 
CRSP130, hSur2 
 
Med24    
ARC/DRIP100, 
CRSP100 
 
Med25    ARC92  
Med26    ARC70,CRSP70  
Med27   Pmc3 TRAP37,CRSP34 N 
Med28    Fksg20  
Med29    Hintersex  
Med30    TRAP25  
Med31 Soh1 M Soh1/Sep10 hSoh1 N 
CDK8 Srb10/Ssn3 K Srb10 CDK8 N 
CDK8L    Cdk11/CDK8L  
CycC Srb11/Ssn8 K Srb11 CycC N 
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The Med6-Med21 interaction is essential in vivo and deletion of N-terminal part of 
Med21 involved in this interaction is lethal. 
Med18 and Med20 are situated on the periphery of the head-middle binding surface and 
are connected to the Med11/17/22 triad via the Med 8 subunit (Cai et al, 2010). Med18 
and Med20 form a functional subcomplex and have a similar effect on global gene 
transcription patterns. Deletion of the Med8 C-terminal domain leads to loss of the 
Med18/Med20 subunits from the purified Mediator and impaired transcriptional 
activity in nuclear extract (Larivière et al, 2008). The Med18/20/8 triad is crucial for 
Mediator interactions with pol II. Genetic studies in S. pombe demonstrated that the  
Med8 C-terminal domain is needed for Mediator-pol II interaction (Mehta et al, 2009) 
and recent EM studies revealed that the Med18 and Med20 subunits mediate contacts 
with pol II via the Rpb4/Rpb7 dimer (Cai et al, 2009; Cai et al, 2010). This interaction 
is crucial since deletion of either Med18 or Med20 in a combination with an rpb4 
deletion causes synthetic lethality.  
Med19, previously reported to be a component of the head module is, instead required 
for connecting the head module to the middle module (Baidoobonso et al, 2007). The 
head module subunits also interact with general transcription factors. The head module 
seems to form multiple contacts with TBP (Cai et al, 2010), interact with TFIIH via its 
Rad3 subunit (Esnault et al, 2008), as well as with transcription factor TFIIF (Takagi et 
al, 2006). 
 
1.3.2.2 The middle module 
The middle module is composed of 7 subunits Med 1, 4, 7, 9, 10, 21, and 31. X-ray 
crystallography data revealed that the highly conserved Med7 and Med21 subunits 
form a flexible hinge that can undergo repositioning of about 10Å. Additionally the 
head module subunit Med6 makes a flexible connection between Med17 of the head 
module and the Med7-Med21 heterodimer of the middle module, interacting with both 
Med21 and Med7 (Baumli et al, 2005). The structural flexibility might explain the 
change in structure between closed and opened conformation observed upon Mediator 
binding to pol II. Med7 is an architectural subunit of the middle domain that is stably 
associated with Med21 via C-terminal domain and Med31 via N-terminal domain 
(Koschubs et al, 2010).  
Further, Med4, Med9 and Med10 are associated with Med7/ Med21 / Med31 
subcomplex.  Med4 interacts with the middle region of Med7 and with Med9. Med1 
and Med10 both bridge between Med7/Med21 and Med4/Med9. Med10 N-terminus is 
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exposed and interacts with Med 14 subunit that connects the tail and middle modules 
(Li et al, 1995). 
 
1.3.2.3 The tail module 
The tail module of the Mediator complex was at first suggested to be specific to S. 
cerevisiae Mediator. It consists of the Med 2, 3, 5, 14, 15 and 16 subunits (Béve et al, 
2005; Guglielmi et al, 2004; Li et al, 1995). The N-terminal portion of the Med14 
subunit interacts with the N-terminal portion of Med10, thus connecting the tail to the 
middle module of S. cerevisiae Mediator (Koschubs et al, 2010). This module is less 
conserved and only half of the six subunits (Med14, Med16 and Med15) have clear 
metazoan homologs (Bourbon et al, 2004). It was also suggested that Med16 plays a 
structural role since Med16 deletion leads to loss the Med2, Med5, Med15/Gal11 and 
Med3/Pgd1 subunits (Béve et al, 2005; Myers et al, 1999; Zhang et al, 2004). 
 
1.3.2.4 The kinase module 
The kinase module consists of the Cdk8 kinase, Cyclin C, Med12, and Med13. The 
kinase module was not identified as a part of transcriptionally active budding yeast 
Mediator (Borggrefe et al, 2002) but has been identified in Mediator isolated from 
higher eukaryotes. The kinase module has been suggested to have repressive function, 
which has been coupled to kinase activity of Cdk8 subunit. First, it was suggested that 
an inhibitory premature phosphorylation of pol II CTD by Cdk8 kinase could prevent 
pol II from entering PIC and thus inhibit transcription initiation (Hengartner et al, 
1998). Second, metazoan Cdk8 could phosphorylate the TFIIH transcription factor, 
thereby inhibiting its ability to phosphorylate pol II CTD and support transcription, 
whereas small (S-) Mediator lacking Cdk8 kinase had a stimulatory effect on 
transcription (Akoulitchev et al, 2000).  
Data from mammalian systems also demonstrated that Mediator like complexes can 
inhibit transcription depending on their association with the kinase module. The 
mammalian ARC-L kinase containing complex and the small CRSP complexes not 
only differ in structure, but also behave differently in transcription assays. In contrast to 
CRSP Mediator, ARC-L could not support activated transcription in vitro (Taatjes et al, 
2002). Interestingly, the kinase associated inhibitory form of Mediator was found to be 
the most common in vivo (Malik & Roeder, 2005). EM studies of S. pombe S- and L-
Mediator complexes from our group demonstrated that pol II and the Cdk8 module 
might compete for the same binding site, therefore the kinase module might suppress 
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transcription independently of the Cdk8 enzymatic activity, simply by occluding pol II 
from binding (Elmlund et al, 2006) papers I-III).  
 
1.3.3 Mediator Recruitment- implications for activation and repression 
The initial idea that Mediator functions simply as a communicator between activators 
and the basal transcription machinery was supported by the identification of many 
putative targets for transcriptional activators within the Mediator complex. First, the 
Mediators prepared from the deletion strains lacking the tail subunits Med2, Med3, and 
Med15 were defective in activation of transcription but could still stimulate basal 
transcription (Lee et al, 1999). Second, Mediator subunits were shown to directly bind 
transcriptional activators. These interactions, even though mainly assigned to tail 
subunits (Gal11-Gcn4 (Herbig et al, 2010; Jedidi et al, 2010; Lee et al, 1999), Gal11-
Gal4 (Jeong et al, 2001), Gal11-Swi5 (Bhoite et al, 2001), Gal11-Pdr1 (Thakur et al, 
2008), Gal11–Oaf1 (Thakur et al, 2009)), were also reported for the core Mediator 
subunit Med17 and Gal4 (Koh et al, 1998).  
Low-resolution pictures demonstrated that mammalian Mediators use different 
interfaces for binding to specific activators (VP-16 and SREBP-1) and that binding 
could induce distinct conformational changes (Taatjes et al, 2004a; Taatjes et al, 2002; 
Taatjes et al, 2004b), giving insight into how a single complex might concert signals 
from a variety of activators. Indeed, in mammalian Mediators particular subunits were 
demonstrated to be targets of transcriptional activators suggesting a mechanism for cell 
specific transcription (Blazek et al, 2005).  
The existence of various forms of Mediator suggests a simple model that both 
activation and repression can be achieved by recruitment of either transcriptionally 
active or inactive Mediators to promoters upon binding of particular transcription 
factors.  
Mo et al. investigated Mediator interactions with the human transcription factor 
CCAT/enhancer binding protein beta (C/EBPβ). C/EBPβ activity is regulated by RAS 
dependent phosphorylation that induces conformational change, turning C/EBPβ from 
repressor to activator. They demonstrated that phosphorylated C/EBPβ could interact 
with S-Mediator and recruit it to target promoter whereas the non-phosphorylated form 
of C/EBPβ recruited L-Mediator (Mo et al, 2004). This finding therefore suggests that 
the recruitment model is valid at least at some promoters. In agreement with this idea, 
  25 
the S. cerevisiae repressor Tup1 has been shown to bind Cdk8 and CycC (Zaman et al, 
2001).  
Contradicting this model, genome-wide chromatin immunoprecipitation data 
demonstrated very similar patterns for the kinase module and core Mediator binding. 
Both the kinase module and core module subunits are bound to IGRs and ORFs of 
transcribed as well as silenced genes (Andrau et al, 2006; Zhu et al, 2006).  
Biochemical data from human systems demonstrated that the kinase module acts as a 
molecular switch between active and non-active forms effectively suppressing 
transcription independently of the kinase activity (Knuesel et al, 2009). These data are 
therefore very similar to the model previously presented for the kinase module in S. 
pombe Mediator (Elmlund et al, 2006). Together these observations suggest that core 
Mediator and the Cdk8 module might be pre-recruited (together or separately) to 
promoter regions making up the platform for rapid gene activation (or repression in 
case of highly transcribed genes). In response to signaling events they would undergo 
rearrangement, promoting the dictated outcome on gene expression level. The 
regulation might be achieved via activator recruitment that might prompt Cdk8 
dissociation from Mediator.  
 
1.3.4 Mediator: multiple roles in transcription 
Studies of metazoan Mediators have established that the co-activator function of 
Mediator is much more complicated than it was initially suggested and acting through 
different mechanisms. Moreover, Mediator is regulated by many different gene specific 
transcription factors and the complex is a target of many intracellular signaling 
pathways (Casamassimi & Napoli, 2007).  
Recent studies demonstrated that Mediator could control gene expression affecting 
chromatin regulation. The Mediator subunit Med12 could selectively assist negative 
transcription regulator REST in gene silencing at target promoters by affecting 
chromatin structure. REST forms a ternary complex with Med12 and the H3K9 
methyltransferase G9a. Recruitment of G9a and inhibitory H3K9 methylation is 
dependent on Med12. Indeed, Med12 knockdown alleviates REST directed repression 
at repressor element 1(RE1) sites (Ding et al, 2008).  
Another example of Mediator promoting chromatin alteration came from biochemical 
analyses of human L-Mediator. Meyer et al. have demonstrated that Cdk8 containing 
L-Mediator can interact with GCN5L histone acetyltransferase and cooperatively 
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phosphoacetylate Ser10/Lys14 on histone 3 in vitro. Moreover, knockdown of Cdk8 
leads to reduction of in vivo histone phosphoacetylation by 80%. GCN5L associated L-
Mediator still had a repressive function in vitro (Meyer et al, 2008). 
  
A number of reports have indicated a role for Mediator in transcription elongation. 
Cell-free transcription experiments in HeLa cells in non-fractionated extracts 
demonstrated that the transcription elongation factor Spt4-Spt5 was required for 
optimal Mediator function (Malik et al, 2007). Another indication that Mediator could 
control a post recruitment step came from studies of serum-activated genes in tumor 
cell lines. ChIP demonstrated that the Cdk8 kinase might promote transcription at 
immediate-early genes upon serum stimulation. Depletion of Cdk8 led to slower 
elongation and impaired pol II CTD phosphorylation in the body of the gene upon 
serum stimulation, whereas pol II occupancy at the targets was generally unaffected. 
Only L-Mediator and not S-Mediator was shown to directly interact with p-TEFb and 
recruitment of this elongation factor was impaired in Cdk8 knockdowns (Donner et al, 
2010).  
Med12 was suggested to regulate embryonic cell pluripotency by regulating expression 
of Nanog dependent genes including Nanog itself in murine ES cells. Microarray 
expression analysis demonstrated a significant overlap of Med12 and Nanog target 
genes. Moreover Med12 and Nanog were enriched at Nanog target promoters under 
proliferation conditions but dissociated upon differentiation (Tutter et al, 2009).  
Recent findings suggested the mechanism for such regulation. Kagey et al. 
demonstrated that Mediator could directly cooperate with the cohesin complex, which 
promotes DNA loop formation between enhancer and core promoter at highly 
expressed pluripotency genes in murine embryonic stem (ES) cells (Kagey et al, 2010). 
A screen for factors needed for maintenance of Oct4 transcription factor expression, 
along with genes coding for known pluripotency transcription factors (Sox2, Oct4, 
Nanog), also identified genes encoding Mediator complex subunits and unexpectedly 
Cohesin complex components. The Cohesin complex is best known for its role in 
mediating sister chromatid cohesion. 
Cohesin subunit Smc1a, cohesin loading factor Nipbl, and Mediator subunit Med12 
were shown to interact with each other and bring together the enhancer and the core 
promoter regions at Oct4 and Nanog transcription factor genes, thus forming and 
stabilizing enhancer-promoter DNA loops. Interestingly these loops were observed 
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only at actively transcribed genes and reduction of Med12 or Smc1a expression led to 
diminished enhancer-core promoter interaction. 
It appears now that Mediator has multiple functions in transcription regulation and 
function as a signal-processor centre for various genetic programs. Apart from the long 
ago established role in RNA polymerase II recruitment upon pre-initiation complex 
assembly, Mediator can also affect transcription at post-recruitment step, contribute to 
chromatin remodeling and thereby promote silencing or transcription depending on the 
context (Malik & Roeder, 2010). 
 
1.4 S. POMBE AS A MODEL ORGANISM 
S. pombe is a useful model system to study eukaryotes for several reasons. It has 
relatively small genome, which was fully sequenced already in 2001 and annotated in 
2002 (Wood et al, 2002). S. cerevisiae has been more frequently used as a model 
system for eukaryotic transcription and S. cerevisiae genes are often better annotated 
compared to S. pombe. On the other hand, S. pombe genome does not seem to show  
evidence of large genome duplication, leading to low redundancy level of the genes and 
simplifying the characterization of protein function (Bähler & Wood, 2004). S. pombe 
has been particularly valuable in studies of molecular basis of cell cycle control (Nurse, 
2002). Large evolutionary divergence between fission and budding yeasts makes S. 
pombe an extremely helpful model organism alongside with S. cerevisiae since 
comparisons between these species can be very useful for extrapolation to other 
eukaryotes. 
Moreover fission yeasts in some aspects are more mammalian-like than budding yeasts, 
e.g. in transcription initiation site position (Choi et al, 2002). Many molecular biology 
techniques developed for S. cerevisiae are generally applicable in S. pombe. Yeasts in 
general are easy to handle, relatively inexpensive and propagate quickly making it is 
easy to obtain a large amount of material in a short time for e.g. biochemical studies. 
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2 RESULTS 
Mediator complex was first isolated from budding yeasts (Flanagan et al, 1991; 
Kelleher et al, 1990; Kim et al, 1994). Identification of metazoan Mediator-like 
complexes with similar function in transcription led to the conclusion that the function 
of Mediator could be evolutionary conserved. However the low primary sequence 
conservation for the majority of Mediator subunits between fungi and metazoan co-
activator complexes seemed to argue against this conclusion and raised the possibility 
that the subunit composition and also molecular function of Mediator might be 
different between yeast and higher eukaryotes.  
At the start of our project, a number of mammalian Mediator-like complexes had been 
described. They could be divided into two large groups, the larger L-Mediators that 
contained a number of additional subunits and also a the conserved CyclinC-CDK8 
kinase pair and the smaller S- or C-Mediator, which lacked CyclinC-CDK8 and many 
other Mediator components, and instead contained one additional component, CRSP70/ 
Med26. 
S. cerevisiae Mediator could be isolated either in free form or in complex with pol II, 
forming a holoenzyme (Myers et al, 1998). Cyclin C and Cdk8 were not present in the 
purified Mediator, but instead purified in complex with two additional yeast proteins, 
Srb8 and Srb9, which lacked clear counterparts in the mammalian Mediator complex.  
When we initiated our work, it was also not clear how conserved the Mediator subunits 
were. Mediator had only been purified from a limited number of species and it was 
therefore difficult to make sequence comparisons. At the time, only eight of the 25-30 
Mediator components were acknowledged to be conserved from yeasts to humans 
(Bourbon et al, 2004; Malik & Roeder, 2000). 
 
Fission yeast Mediator had previously been purified as a holoenzyme by conventional 
chromatography in association with pol II (Spåhr et al, 2001). The fission yeast 
Mediator was significantly smaller then S. cerevisiae or mammalian Mediator-like 
complexes and only contained 13 subunits, possibly due to partial protein degradation 
in course of purification or loss of loosely associated subunits. We wished to better 
characterize the S. pombe Mediator complex and to address the question of whether any 
alternative forms of Mediator existed, similarly to the situation in higher eukaryotes. 
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2.1.1 Paper I 
We decided to take advantage of Tandem Affinity Purification (TAP) method in 
combination with optimized whole cell extract preparation in order to diminish 
proteolysis. 
We introduced a TAP-tag on the core subunit Med7 and isolated a Mediator complex, 
containing two additional high molecular weight subunits homologous to S. cerevisiae 
Srb8 and human TRAR240 respectively according to BLAST sequence similarity 
searches. Interestingly, the newly identified polypeptides, as well as pol II subunits, 
were present in substoichiometric amounts to the core Mediator component 
Med14/Rgr1. We assumed that our preparation might be a mixture of various forms of 
Mediator. Affinity purification of spTrap240-TAP cell extract allowed us to isolate the 
alternative form of fission yeast Mediator near to homogeneity. In addition to 
spTrap240 and spSrb8, it also contained the two smaller subunits homologous to 
budding yeast Cyclin Dependent Kinase Srb10 and Cyclin Srb11. We assumed that the 
four indicated subunits might form a submodule. In support of this notion spSrb8 and 
spTrap240 had similar effect on gene expression, repressing the same subset of genes. 
Surprisingly, in contrast to the holoenzyme form of Mediator, no components of pol II 
were identified in the L-Mediator preparation. We thus demonstrated that fission yeast 
Mediator can exist in at least two different forms. The larger form does not interact 
with pol II in contrast to the smaller one that forms holoenzyme with pol II.  
We proposed that the four subunit kinase subcomplex formed an evolutionary 
conserved Srb8-11 kinase module with spTrap240 and spTrap230 being bona fide 
homologs of Srb9 and Srb8. Our findings therefore provided a simplified model for 
Mediator organization and helped to connect findings in mammalian cells with 
observations in yeast. 
 
2.1.2 Paper II 
Using the TAP-method we purified the Mediator-pol II holoenzyme from the 
Δmed13/trap240. This Mediator also lacked the Cdk8 kinase activity, so we assumed 
that Med13/spTrap240 is a subunit required for anchoring the kinase module to the core 
Mediator. We did not address the subunit organization in this paper (see paper III for 
details). 
Having established a reliable protocol for isolation of Mediator to homogeneity, we 
wished to test its function as co-activator in a reconstituted in vitro transcription 
  30 
system. We decided to create an S. pombe cell-free transcription system from highly 
purified general transcription factors. Depending on the complexity of a particular 
factor we employed different strategies for protein purification and expression. The 
large multisubunit complexes, such as pol II, five-subunit core-TFIIH and the TFIIH-
kinase module (TFIIK) were isolated from whole yeast cell extract. Pol II was 
immunoprecipitated using antibodies directed against pol II CTD. The submodules of 
TFIIH were isolated using TAP-purification. 
The His-tagged recombinant single subunit TFIIB factor was overexpressed in E.coli. 
The His-tagged recombinant two-subunit TFIIE and three-subunit TFIIF were over-
expressed in insect cells by co-expression of baculoviruses expressing the respective 
subunits. All recombinant factors were Ni-affinity purified and then subjected to ion-
exchange chromatography.  
We reconstituted an in vitro transcription system of S. pombe GTF together with S. 
cerevisiae TBP from nucleosome-free adh1-promoter containing template. We 
compared the effects of the holoenzyme and kinase-containing Mediator on basal 
transcription. 
The Mediator holoenzyme stimulated basal transcription in our reconstituted in vitro 
transcription system, whereas the L-Mediator effectively suppressed transcription in a 
dose dependent manner. 
  
2.1.3 Paper III 
We earlier demonstrated that deletion of Med13 led to loss of Cdk8-kinase from 
Mediator. EM structural analysis of the C- and L-Mediator states have implied that 
inability of L-Mediator to interact with pol II is caused by sterical hindrances rather 
than enzymatic activities of the kinase module (Elmlund et al, 2006). Cdk8 module 
presence is sufficient to block pol II binding. EM data suggest that the Cdk8 module 
forms a molecular lid that might cover the pol II binding interface. 
Now we decided to further systematically investigate the subunit architecture within the 
kinase module of L-Mediator. We generated deletion strains for the kinase module 
subunits in the Med7-TAP and Med13-TAP backgrounds and analyzed subunit 
composition of isolated Mediators by immunoblotting. The TAP-tag has a significant 
size and it could potentially disturb interactions within the complex, being a possible 
cause for pol II dissociation. To rule out this possibility we also included in our analysis 
preparations from strains bearing TAP-tag on CyclinC/Srb11. 
  31 
We found that Med13 was indeed the subunit anchoring the kinase module to the core 
Mediator since Med12, Cdk8 and CycC were lost from the Δmed13 holoenzyme. The 
kinase activity or physical presence of Cdk8 was not required for L-Mediator 
formation. Instead stability of Med12 association was dependent on Cdk8 presence 
since deletion of Cdk8 caused significant loss of Med12. The knock-out of the Cdk-
cyclin pair had a similar effect on Med12 association with C-Mediator. Interestingly, 
CycC remained associated with Mediator in Δcdk8 Mediator preparations however its 
amount was reduced. We demonstrated that the deletion of different subunits of the 
kinase module has different consequences for architecture of the Cdk8 module, thus 
suggesting step-wise structural organization of subunits in the kinase module. 
In agreement with our previous assumptions the sterical hindrance and not Cdk8 kinase 
activity seemed to be a predominant factor preventing pol II–Mediator association. 
Med 13 seemed to present the major obstacle for pol II binding given that Cdk8, CycC 
and probably also Med12 were not absolutely required to block pol II interactions. 
The different behavior of the C- and L-Mediator in transcription, as well as data 
arguing for the repressive function of the kinase module in both budding and fission 
yeasts (paper I), induced the question of how regulation of activation and repression 
might be achieved. 
Earlier reports from the human system speculated that only small CRSP, but not the 
large ARC-L complex could interact with the CTD of pol II, since only small Mediator 
could be pulled down by recombinant CTD from HeLa nuclear extract (Näär et al, 
2002).  
Using our highly homogenous Mediator preparations in a CTD binding assay we could 
demonstrate that S-Mediator indeed binds the CTD (not shown). Surprisingly, we 
detected the core Mediator subunits in the bound fraction from L-Mediator as well. By 
immunoprecipitation experiments we demonstrated that an excess of CTD could 
effectively displace the kinase submodule from L-Mediator and bind S-Mediator. The 
number of CTD repeats as well as the phosphorylation state of the CTD was of 
importance. Only non-phosphorylated CTD longer than 11 repeats could effectively 
displace the kinase module from the rest of Mediator. The phosphorylation of CTD 
completely abolished its ability to bind Mediator.  
It is feasible that interaction with activators or repressors might play a role in transition 
between a transcriptionally inactive and active states of Mediator.  
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2.1.4 Paper IV 
We focused on characterization of the putative component of fission yeast Mediator 
Med15. Med15 is a conserved component of the Mediator in many species, but so far 
we were not able to identify it as a component of fission yeast Mediator despite the fact 
that the S. pombe genome encodes a Med15 orthologue, presumably because of 
degradation issues. We purified L-Mediator from the yeast extract, prepared under 
conditions that diminish proteolysis. A polypeptide around 140 kDa was identified as S. 
pombe Med15. Judging from the relative intensities of the bands on the Coomassie 
stained gel we estimated Med15 to be present in 10-15% of all L-Mediator complexes. 
We also introduced the tandem C-Terminal FLAG-tag on Med15 and purified Med15 
by immunoprecipitaion. We found Med15-FLAG associated with the single 
polypeptide identified as Hrp1, a CHD1 ATP-dependent chromatin-remodeling protein. 
Interestingly, other Mediator components were absent in the Med15-FLAG 
preparations, suggesting that Med15 is not a stable component of the Mediator 
complex. Co-immunoprecipitation using anti-Hrp1 antibodies confirmed Med15-Hrp1 
association. Previously we were not able to identify Med15 in our holoenzyme 
preparation. We directed antibodies against Med15 and analyzed pol II holoenzyme- 
and L-Mediator preparations by immunoblotting. We found that both Med15 and Hrp1 
are present in L-Mediator but are absent from core Mediator. We concluded that 
Med15 and Hrp1 might form a subcomplex and that the two proteins are transient 
components of the L-Mediator complex. We next explored if the physical interaction 
might also reflect a functional interaction between Med15 and Hrp1. To do so we 
investigated genome wide transcription profiles in Δmed15 or Δhrp1 mutants using the 
Affimetrix microarray platform. Med15 deletion had larger effects on gene expression, 
but no fewer than half of the genes that are up-regulated in Δhrp1 were also up-
regulated in Δmed15. 
To find in vivo targets for Med15 and Hrp1 binding we performed genome-wide ChIP-
chip analysis. In this study we used S. pombe spotted arrays that contained PCR 
products corresponding to 500 base pairs fragments upstream from the translation start 
site (InterGenicRegions) and the last 500 base pairs of the coding regions (ORFs). Each 
array contained 4.960 IGR and 4.976 ORF fragments spotted in duplicates. 
A significant overlap in binding targets for Med15 and Hrp1 in IGRs (p=6,55X10-81 ) 
as well as coding regions (p=1,22X10-14 ) suggested that the two proteins might act at 
the same genomic locations. 
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We had earlier established a role for Hrp1 in nucleosome disassembly (Walfridsson et 
al, 2007). Comparison of Med15 and Hrp1 binding maps with H3 density maps 
demonstrated that Hrp1 and Med15 are both localized to regions with high H3 density. 
Analysis of the histone density at selected common Med15 and Hrp1 bound promoters 
in Δmed15 did not show any significant changes in H3 density, but instead indicated an 
increased occupancy by Hrp1, suggesting that Med15 might play a role in removing 
Hrp1 from specific promoters.  
 
2.2 CONCLUDING REMARKS 
Work presented in this thesis has in our opinion contributed to our understanding of the 
function and organization of the conserved Mediator complex. Our purification strategy 
allowed us to obtain highly homologous preparations that made possible EM 
characterization of S. pombe Mediator (Elmlund et al, 2006). The isolation of the two 
various form of yeast Mediator complex that are similar in composition and 
transcriptional behavior to metazoan Mediators helped to establish the evoluationary 
conserved structure and function of Mediator complex (Paper I, II). Since the kinase 
module was not identified as a part of budding yeast Mediator, S. pombe Mediator is a 
good choice to address the architecture of kinase submodule by biochemical means. 
Analysis of subunit composition of Mediators purified from deletion strains for Cdk8 
module components clarified the subunit organization within the kinase module of S. 
pombe Mediator. We demonstrated that core Mediator association with pol II and 
kinase module are mutually exclusive and that Med13 subunit rather than Cdk8 itself is 
the key subunit that blocks interaction with pol II (PaperIII).  
We have also addressed the possible mechanisms of transition between 
transcriptionally incompetent L-Mediator and transcriptionally active S-Mediator. We 
suggest that interaction with non-phosphorylated pol II CTD might contribute in 
weakening Cdk8 module-S-Mediator contacts and promote kinase module dissociation 
upon transcription initiation. Other factors (e.g. binding of activators or repressors) 
might contribute to this transition, perhaps by changing Mediator conformation to 
alleviate   pol II binding or contrary stabilizing the Cdk bound state to promote 
repression.  
While trying to characterize putative Mediator subunit Med15 we were surprised to 
find it in association with chromatin remodeling protein Hrp1. Perhaps S. pombe 
Mediator association with Hrp1 should not be surprising in the view of emerging 
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information concerning multiple modes of Mediator action. Our work did not 
conclusively establish the functional role for Hrp1 in Mediator function, but has opened 
a door for future studies.   
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